Columnists
Tipsheet
Cartoons
Podcasts
Newsletters
Sections
Podcasts
Townhall TV
Election
Capitol Voices
Entertainment
Radio News
Live Blog
Topics
Sites
Hot Air
PJ Media
Bearing Arms
Twitchy
RedState
JOIN VIP
LOGIN
MY ACCOUNT
Account Settings
Newsletter Subscriptions
Log Out
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Artara Therapeutics Inc
(NQ:
TARA
)
1.955
-0.145 (-6.90%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jun 26, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
268,442
Open
2.070
Bid (Size)
1.950 (4)
Ask (Size)
1.960 (4)
Prev. Close
2.100
Today's Range
1.880 - 2.090
52wk Range
1.040 - 5.240
Shares Outstanding
11,235,731
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
TARA Stock Earnings: Protara Therapeutics Misses EPS for Q1 2024
May 02, 2024
TARA stock results show that Protara Therapeutics missed analyst estimates for earnings per share the first quarter of 2024.
Via
InvestorPlace
Alphabet To Rally Around 14%? Here Are 10 Top Analyst Forecasts For Monday
April 22, 2024
Via
Benzinga
Performance
YTD
-6.90%
-6.90%
1 Month
-29.93%
-29.93%
3 Month
-51.12%
-51.12%
6 Month
+3.99%
+3.99%
1 Year
-18.20%
-18.20%
More News
Read More
Protara Therapeutics Shares Interim Data From Bladder Cancer Study, Raises $45M Via Equity
April 05, 2024
Via
Benzinga
Exposures
Product Safety
12 Health Care Stocks Moving In Friday's Pre-Market Session
April 05, 2024
Via
Benzinga
3 Stocks That Could Help You Retire on a Private Island
March 23, 2024
Via
InvestorPlace
Recap: Protara Therapeutics Q1 Earnings
May 04, 2023
Via
Benzinga
Protara Therapeutics Releases Early Cut Data From Investigational Cell-Based Therapy For Bladder Cancer
April 28, 2023
Via
Benzinga
Protara Therapeutics Shares Retrospective Analysis Of OK-432 In Rare Lymphatic Malformations
May 12, 2022
Via
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
March 04, 2024
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
December 11, 2023
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
July 10, 2023
Via
Benzinga
Protara Therapeutics: Q3 Earnings Insights
November 03, 2022
Via
Benzinga
Insider Buying 2022: 15 Stocks to Bet On Despite the Bear Market
October 05, 2022
Via
InvestorPlace
Stocks That Hit 52-Week Lows On Wednesday
May 11, 2022
Via
Benzinga
Stocks That Hit 52-Week Lows On Monday
October 02, 2023
Via
Benzinga
Executives Buy Around $35M Of 4 Penny Stocks: Nextdoor, GreenLight Biosciences And More
August 16, 2022
Via
Benzinga
Stocks That Hit 52-Week Lows On Friday
September 15, 2023
Via
Benzinga
Stocks That Hit 52-Week Lows On Tuesday
May 03, 2022
Via
Benzinga
Stocks That Hit 52-Week Lows On Monday
September 11, 2023
Via
Benzinga
Recap: Protara Therapeutics Q4 Earnings
March 09, 2022
Via
Benzinga
Stocks That Hit 52-Week Lows On Friday
September 08, 2023
Via
Benzinga
Stocks That Hit 52-Week Lows On Wednesday
November 09, 2022
Via
Benzinga
Stocks That Hit 52-Week Lows On Wednesday
May 04, 2022
Via
Benzinga
Stocks That Hit 52-Week Lows On Friday
April 29, 2022
Via
Benzinga
Stocks That Hit 52-Week Lows On Tuesday
March 08, 2022
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.